Articles Vol. 63 No. chuyên đề 3-HN Sản Nhi Nghệ An (2022) 30/11/2022

ASSESSMENT OF THE RESULTS OF NEWBORN SCREENING BY HEALTH BLOOD LETS AT NGHỆ AN OBSTETRICS AND PEDIATRICS HOSPITAL FROM JANUARY TO JUNE 2022

Tang Xuan Hai1,2, Nguyen Thi Van1,2, Nguyen Thi Tho May1,2, Nguyen Sy Tuan Anh1,2
1 Nghe An Hospital of Obstetrics and Pediatrics
2 Bệnh viện Sản Nhi Nghệ An
Corresponding author: bstangxuanhai@gmail.com
DOI: 10.52163/yhc.v63i8.507
38 Views
0 Downloads
Abstract

Background: Newborn Screening is a screening program that helps to detect common and
treatable or preventable congenital metabolic-endocrine and genetic disorders in newborn babies.
Detected through a screening test kit for 5 diseases: G6PD deficiency, congenital hypothyroidism,
congenital adrenal hyperplasia, Galactosemia, Phenylketonuria
Objectives: Determine the rate of newborns at high risk of 5 diseases and the relationship with
epidemiological factors.
Methods: Using cross-sectional descriptive method for newborns full 24-72 hours old born at
Nghe An Obstetrics and Pediatrics Hospital from January 2022 to June 2022.
Results: Through surveying 3147 samples of heel in newborns, we found that the abnormal rate
of newborn screening tests accounted for the following: G6PD deficiency accounted for 0,86%, of
which, male accounted for 70,37%, girls account for 29.63%. Congenital hypothyroidism is
0.22%. Congenital adrenal hyperplasia is 0,13%. Phenylketonuria was 0,1% and none of the
children were in the high-risk group for galactosemia.
Conclusions: 5 newborn screening diseases, if detected early, can be prevented and treated so
that children can have a completely healthy life. Therefore, it is necessary to strengthen screening
counseling to improve population quality and improve living standards.

References
[1]
Ngô Thị Bình Minh, Phạm Thanh Long & Google Scholar
[2]
cs, “ Nghiên cứu khảo sát tỷ lệ bất thường của Google Scholar
[3]
xét nghiệm sàng lọc sơ sinh tại Bệnh viện Đại Google Scholar
[4]
học Y Dược thành phố Hồ Chí Minh”, Nghiên Google Scholar
[5]
cứu Y học, 2021, 25,2. Google Scholar
[6]
Nguyễn Thu Nhạn, “Sàng lọc sơ sinh biện Google Scholar
[7]
pháp để phát hiện sớm bệnh lý rối loạn nội tiết Google Scholar
[8]
– chuyển hóa và di truyền”, Tạp chí Nhi khoa, Google Scholar
[9]
[10]
Nguyễn Thị Nhiên, “ Đề án tầm soát, Google Scholar
[11]
chẩn đoán, điều trị một số bệnh, tật trước sinh Google Scholar
[12]
và sơ sinh: Giảm gánh nặng bệnh tật bẩm sinh, Google Scholar
[13]
nâng cao chất lượng dân số”, Bộ Y tế, 2010. Google Scholar
[14]
Adill M.Allahverdi yev, Malahat Google Scholar
[15]
Bagirova, “ glucose-6-phosphat Google Scholar
[16]
Dehydrogenase. Deficiency and malaria: Google Scholar
[17]
Amethod to detect primaquine – Induced Google Scholar
[18]
Hemolysis in vitro”, 2012. Google Scholar
[19]
Ella T Nkhoma, Charles poole, “ the Google Scholar
[20]
global prevalence of glucose-6-phosphate Google Scholar
[21]
dehydrogenase deficiency : asystematic review Google Scholar
[22]
and meta – analysis”, Blood cells, Molecules Google Scholar
[23]
&Diseases, 2009, 42(3):267-78. Google Scholar
[24]
Gerard berry, MD, “Galactosemia”, Google Scholar
[25]
Boston children’s Hospital, 2012. Google Scholar
[26]
Guideto G6PD deficiency rapid Google Scholar
[27]
diagnostic testing to support p.vivax radical Google Scholar
[28]
cure”, world Health organization, global Google Scholar
[29]
Malaria programme, 2018. Google Scholar
[30]
Valaree Don Francecci, “ Newborn Google Scholar
[31]
Screening: History, Future and awareness Google Scholar
[32]
month”, 2021. Google Scholar